BBIO logo

BridgeBio Pharma, Inc. (BBIO) EBIT

Annual EBIT:

-$442.90M+$129.06M(+22.56%)
December 31, 2024

Summary

  • As of today, BBIO annual earnings before interest & taxes is -$442.90 million, with the most recent change of +$129.06 million (+22.56%) on December 31, 2024.
  • During the last 3 years, BBIO annual EBIT has risen by +$96.77 million (+17.93%).
  • BBIO annual EBIT is now -910.76% below its all-time high of -$43.82 million, reached on December 31, 2017.

Performance

BBIO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Quarterly EBIT:

-$136.36M-$2.88M(-2.16%)
September 30, 2025

Summary

  • As of today, BBIO quarterly earnings before interest & taxes is -$136.36 million, with the most recent change of -$2.88 million (-2.16%) on September 30, 2025.
  • Over the past year, BBIO quarterly EBIT has increased by +$50.77 million (+27.13%).
  • BBIO quarterly EBIT is now -3743.01% below its all-time high of $3.74 million, reached on March 31, 2024.

Performance

BBIO Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

TTM EBIT:

-$594.97M+$50.77M(+7.86%)
September 30, 2025

Summary

  • As of today, BBIO TTM earnings before interest & taxes is -$594.97 million, with the most recent change of +$50.77 million (+7.86%) on September 30, 2025.
  • Over the past year, BBIO TTM EBIT has dropped by -$62.27 million (-11.69%).
  • BBIO TTM EBIT is now -1322.07% below its all-time high of -$41.84 million, reached on March 31, 2018.

Performance

BBIO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BBIO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+22.6%+27.1%-11.7%
3Y3 Years+17.9%-9.9%-15.7%
5Y5 Years-58.3%-13.7%-39.8%

BBIO EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-9.6%+22.6%-3743.0%+38.4%-35.1%+13.1%
5Y5-Year-58.3%+22.6%-3743.0%+38.4%-39.8%+13.1%
All-TimeAll-Time-910.8%+22.6%-3743.0%+38.4%-1322.1%+13.1%

BBIO EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$136.36M(-2.2%)
-$594.97M(+7.9%)
Jun 2025
-
-$133.47M(-28.6%)
-$645.74M(+5.7%)
Mar 2025
-
-$103.80M(+53.1%)
-$684.91M(-18.6%)
Dec 2024
-$442.90M(+22.6%)
-$221.33M(-18.3%)
-$577.37M(-8.4%)
Sep 2024
-
-$187.13M(-8.4%)
-$532.70M(-5.9%)
Jun 2024
-
-$172.65M(-4712.6%)
-$502.99M(-6.4%)
Mar 2024
-
$3.74M(+102.1%)
-$472.91M(+21.1%)
Dec 2023
-$571.96M(-41.5%)
-$176.66M(-12.2%)
-$599.44M(-10.1%)
Sep 2023
-
-$157.42M(-10.4%)
-$544.32M(-6.5%)
Jun 2023
-
-$142.57M(-16.1%)
-$511.00M(-16.1%)
Mar 2023
-
-$122.79M(-1.0%)
-$440.21M(+6.0%)
Dec 2022
-$404.21M(+25.1%)
-$121.54M(+2.1%)
-$468.44M(+8.9%)
Sep 2022
-
-$124.10M(-72.9%)
-$514.06M(+4.7%)
Jun 2022
-
-$71.78M(+52.5%)
-$539.46M(+4.0%)
Mar 2022
-
-$151.02M(+9.7%)
-$561.70M(+2.9%)
Dec 2021
-$539.68M
-$167.16M(-11.8%)
-$578.18M(-7.4%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$149.50M(-59.0%)
-$538.51M(-5.8%)
Jun 2021
-
-$94.02M(+43.9%)
-$508.95M(+5.7%)
Mar 2021
-
-$167.50M(-31.4%)
-$539.50M(-13.7%)
Dec 2020
-$468.83M(-67.5%)
-$127.49M(-6.3%)
-$474.48M(-11.5%)
Sep 2020
-
-$119.94M(+3.7%)
-$425.63M(-18.2%)
Jun 2020
-
-$124.57M(-21.5%)
-$360.22M(-18.1%)
Mar 2020
-
-$102.49M(-30.3%)
-$304.98M(-14.5%)
Dec 2019
-$279.82M(-67.7%)
-$78.64M(-44.2%)
-$266.24M(-41.9%)
Sep 2019
-
-$54.53M(+21.3%)
-$187.60M(-7.5%)
Jun 2019
-
-$69.32M(-8.7%)
-$174.53M(-24.7%)
Mar 2019
-
-$63.75M(-53.8%)
-$139.99M(-18.6%)
Dec 2018
-$166.90M(-280.9%)
-
-
Sep 2018
-
-$41.46M(-19.2%)
-$118.08M(-54.1%)
Jun 2018
-
-$34.78M(+16.9%)
-$76.62M(-83.1%)
Mar 2018
-
-$41.84M
-$41.84M
Dec 2017
-$43.82M
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual EBIT year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly EBIT year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM EBIT year-on-year change?

What is BridgeBio Pharma, Inc. annual earnings before interest & taxes?

The current annual EBIT of BBIO is -$442.90M

What is the all-time high annual EBIT for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual earnings before interest & taxes is -$43.82M

What is BridgeBio Pharma, Inc. annual EBIT year-on-year change?

Over the past year, BBIO annual earnings before interest & taxes has changed by +$129.06M (+22.56%)

What is BridgeBio Pharma, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of BBIO is -$136.36M

What is the all-time high quarterly EBIT for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly earnings before interest & taxes is $3.74M

What is BridgeBio Pharma, Inc. quarterly EBIT year-on-year change?

Over the past year, BBIO quarterly earnings before interest & taxes has changed by +$50.77M (+27.13%)

What is BridgeBio Pharma, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of BBIO is -$594.97M

What is the all-time high TTM EBIT for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM earnings before interest & taxes is -$41.84M

What is BridgeBio Pharma, Inc. TTM EBIT year-on-year change?

Over the past year, BBIO TTM earnings before interest & taxes has changed by -$62.27M (-11.69%)
On this page